Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

1. Short-term dietary weight loss targeting hepatic fat reduction was associated with measurable improvements in arterial stiffness, endothelial function, and cardiovascular risk scores in metabolic dysfunction-associated steatotic liver disease (MASLD) patients. 2. These vascular improvements did not correlate directly with the magnitude of hepatic triglyceride reduction, suggesting the vascular…